IO BIOTECH ApS: Financial statements 2021
CVR: 36474483
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
IO BIOTECH ApS (CVR 36474483) has filed annual accounts for 2021. In 2021, the company reported a net result of DKK -240,410,969 compared with DKK -65,160,755 the year before. Equity in the 2021 report amounted to DKK 722,778,511. The solvency ratio was 90%. The company had 15 employees in the financial year.
- Profit/Loss
- DKK -240,410,969
- Equity
- DKK 722,778,511
- Total Assets
- DKK 803,145,267
- Employees
- 15
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | - | -240.4 mio. | 722.8 mio. | 15 |
| 2020 | - | - | -65.2 mio. | 17.5 mio. | - |
| 2019 | - | - | -68.7 mio. | -13.9 mio. | 12 |
| 2018 | - | - | -51.3 mio. | 54.8 mio. | 11 |
| 2017 | - | - | -25.1 mio. | 44.3 mio. | 6 |
Official annual report
Find more companies like IO BIOTECH ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
As of October 29, 2021, is registered as an owner of IO BIOTECH ApS with an ownership share of 100%.
IO BIOTECH ApS has published its annual report for 2020. The net result was DKK -65,160,755.
As of January 15, 2021, Jack Bech Nielsen has joined the board of directors of IO BIOTECH ApS.
As of January 15, 2021, Vanessa Malier has joined the board of directors of IO BIOTECH ApS.
As of January 15, 2021, Priyanka Belawat has joined the board of directors of IO BIOTECH ApS.
As of January 15, 2021, Mads Hald Andersen has left the board of directors of IO BIOTECH ApS.
About IO BIOTECH ApS
IO BIOTECH ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2014. The company is under bankruptcy. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company is owned by IO Biotech Inc.. The company has 9 employees (2026). In 2024, the company reported a net result of EUR -84,833,635 compared with EUR -76,648,917 the year before. Equity in the 2024 report amounted to EUR -6,630,183.